Skip to main content

New System for Treating Cancer Seen as Hopeful

Published: The New York Times Author: Andrew Pollack Date: June 2, 2014 Full Article: http://www.nytimes.com/2014/06/03/business/cancer-researchers-report-longer-survival-rates-with-immunotherapy.html?ref=health&_r=1 Discussing some success and buzz around immunotherapy to target certain…

Our Effort

Open Therapeutics is a major backer of open science and open access efforts.

Open Therapeutics freely provides to science, technology, engineering, and math (STEM) scientists, or another other seriously interested persons, intellectual properties (patents, etc.), grant funding, lab equipment, document development tools, and preprint server in a collaboration platform (Therapoid™).

When the researchers advance the intellectual properties, s/he gains ScienceCoins™; a blockchain-based cryptocurrency.